Nasdaq · Healthcare
Seer, Inc. (SEER)
As-reported financials and recent SEC filings for Seer, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$16.6M
Net income
$-73.6M
Net margin
—
Diluted EPS
—
ROE
-28.4%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $16.6M | $14.2M | $16.7M | $15.5M | $6.6M |
| Gross profit | $8.5M | $7.1M | $8.5M | $7.1M | $3.4M |
| Operating income | $-78.0M | $-100.1M | $-103.5M | $-97.2M | $-71.5M |
| Net income | $-73.6M | $-86.6M | $-86.3M | $-93.0M | $-71.2M |
| Diluted EPS | — | — | $-1.35 | $-1.49 | $-1.17 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
DEFA14A2026-07-06
View on EDGAR →DEFA14A2026-07-06
View on EDGAR →DEFA14A2026-07-06
View on EDGAR →DEFA14A2026-07-06
View on EDGAR →DFAN14A2026-07-06
View on EDGAR →8-K2026-07-02
View on EDGAR →DFAN14A2026-06-29
View on EDGAR →DFAN14A2026-06-24
View on EDGAR →Largest Healthcare peers
Go deeper on SEER
Search Seer, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.